Denise L. Faustman, MD, PhD, Director of Immunobiology, Massachusetts General Hospital & Associate Professor of Medicine, Harvard Medical School
Denise Faustman, MD, PhD, is Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School. She is currently leading a human clinical trial program to test the efficacy of the BCG vaccine as a treatment to reverse long-term type 1 diabetes. They are currently preparing to enroll patients in a Phase II study. Dr. Faustman’s research has been highlighted in publications including The Wall Street Journal, The New York Times, Los Angeles Times, and Scientific American. She earned her MD and PhD from Washington University School of Medicine in St. Louis, Missouri, and completed her internship, residency, and fellowships in internal medicine and endocrinology at the Massachusetts General Hospital.